Exploring new pain relief options from Cameroonian plants
Official title: From traditional medicine to innovation: Discovering novel analgesics targeting calcium modulation from Cameroonian phytochemicals
Funded at University of Kentucky · NIH-10986264 · Data updated 2026-11-12
This study is exploring new pain relief options made from plants used in traditional Cameroonian medicine, aiming to find natural ways to help people manage chronic pain without using opioids.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $360,514 |
| NIH project number | 1R21AT013164-01 |
| Project ID | NIH-10986264 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from chronic pain conditions who are seeking alternative pain relief options.
✕Less likely to help
Patients who do not experience chronic pain or those who are currently managing their pain effectively with existing treatments may not benefit from this research.
What this research studies
This research investigates the potential of novel compounds derived from traditional Cameroonian plants to provide non-opioid pain relief. By focusing on calcium modulation through a specific protein target, the study aims to isolate and test bioactive compounds that could alleviate chronic pain. The research involves collaboration between institutions in Cameroon and the United States, utilizing both animal models and laboratory assays to evaluate the effectiveness of these compounds. Patients may benefit from innovative pain management solutions that are rooted in traditional medicine.
Why it matters
Potential benefit: If successful, this research could lead to new, effective non-opioid analgesics for chronic pain management.
How similar studies have gone: Preliminary studies have shown promising results with similar approaches, indicating potential for success in this novel research.
Where this research is happening
-
University of Kentucky
Lexington, United States Active
Researchers
- Principal investigator: Tidgewell, Kevin Joseph — University of Kentucky
- Study coordinator: Tidgewell, Kevin Joseph
Related research
Other NIH-funded projects on the same topics.
-
East Palestine health impact study following train derailment
A community-engaged study in East Palestine will follow residents to understand health symptoms, exposure markers, and air quality after a major train derailment.
-
Grade C Periodontitis in Young People: Genetic Clues to a Severe, Early Condition
A research team is studying why some young people develop a severe form of gum disease called Grade C periodontitis and how genetics and bacteria like Aa may contribute.
-
Regulation of exon junction complex in cancer biology
This grant studies how a key molecular complex that controls RNA processing acts in cancer, with the aim of understanding how it contributes to cancer cell behavior.
-
Alcohol use and suicidal thoughts: how decision-making affects risk
This project looks at how acute alcohol use and people’s decision-making patterns relate to suicidal thoughts and behaviors in adults.
-
Kentucky workplace health surveillance program improving safety for workers
A national institute-funded program is supporting Kentucky to monitor and improve safety and health at work for better protection of workers.
-
Gabapentin use in older adults and related health outcomes
This project will look at how gabapentin is used by older adults and whether that use is linked to health outcomes using Medicare data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.